Le médicament candidat de phase 1 GLR2007, développé par Gan & Lee, a reçu la désignation Fast Track de la FDA américaine ...Middle East

PEKIN et BRIDGEWATER, New Jersey, 31 janvier 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co. (ci-après dénommée Gan & Lee) (Shanghai : 603087.SH), une société biopharmaceutique internationale, a annoncé aujourd'hui que la Food and Drug Administration (FDA) américaine a accordé la...

Hence then, the article about le medicament candidat de phase 1 glr2007 developpe par gan lee a recu la designation fast track de la fda americaine was published today ( Sunday 31/01/2021 - 01:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Le médicament candidat de phase 1 GLR2007, développé par Gan & Lee, a reçu la désignation Fast Track de la FDA américaine )

Also on site :

• One person in critical condition following two-vehicle collision on SR-126 at Boosey Road
• Kentucky congressman announces death of longtime staffer, campaign manager
• Supermarket timings for Boxing Day and New Year revealed for Asda, Tesco, Sainsbury’s, Aldi, Lidl and more